Paraneoplastic syndrome: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 21: | Line 21: | ||
==[[Paraneoplastic syndrome history and symptoms|History & Symptoms]]== | ==[[Paraneoplastic syndrome history and symptoms|History & Symptoms]]== | ||
==[[Paraneoplastic syndrome medical therapy|Medical Therapy]]== | ==[[Paraneoplastic syndrome medical therapy|Medical Therapy]]== | ||
Treatment options include: | Treatment options include: |
Revision as of 19:59, 20 January 2012
Paraneoplastic syndrome | |
DiseasesDB | 2064 |
---|---|
MeSH | D010257 |
Paraneoplastic syndrome Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Classification
History & Symptoms
Medical Therapy
Treatment options include:
- Therapies to eliminate the underlying cancer such as chemotherapy, radiation and surgery, and
- Therapies to reduce or slow neurological degeneration. Rapid diagnosis and treatment is critical for the patient to have the best chance of recovery. Since these disorders are relatively rare, few doctors have seen or treated PNDs. Therefore, it is important that PND patients consult with a specialist with experience in diagnosing and treating paraneoplastic neurological disorders.
Organizations
The International Paraneoplastic Association (IPA) is an organization dedicated to providing support and information to those affected by paraneoplastic neurological disorders.
References
External links
- Neuroimmunology, The Medical School, Birmingham University - Paraneoplastic neurological autoantibodies, Birmingham UK
de:Paraneoplastisches Syndrom Template:WH Template:WikiDoc Sources